Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2002 October;54(5) > Minerva Pediatrica 2002 October;54(5):365-72

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532


eTOC

 

REVIEWS  


Minerva Pediatrica 2002 October;54(5):365-72

language: English

Growth hormone treatment in children with cystic fibrosis

Hardin D. S.


PDF  


Children with cystic fibrosis (CF) have problems with poor linear growth and inadequate weight gain. Nutritional augmentation has been the mainstay of therapy for improving both weight and height in CF; however inadequate growth continues to be a problem. Furthermore, protein catabolism has been documented even in non-acutely ill adults and children with CF, and could adversely affect longitudinal growth. Human recombinant growth hormone (GH) has positive effects on nitrogen balance, and multiple studies have demonstrated improved height and weight in children treated with GH. The purpose of this article is to summarize studies evaluating GH use in children with CF.

top of page

Publication History

Cite this article as

Corresponding author e-mail